Show simple item record

dc.contributor.authorGurwitz, Jerry H
dc.contributor.authorQuinn, Charlene C
dc.contributor.authorAbi-Elias, Ivan H
dc.contributor.authorAdams, Alyce S
dc.contributor.authorBartel, Rosie
dc.contributor.authorBonner, Alice
dc.contributor.authorBoxer, Rebecca
dc.contributor.authorDelude, Christopher
dc.contributor.authorGifford, David
dc.contributor.authorHanson, Bruce
dc.contributor.authorIto, Kouta
dc.contributor.authorJain, Paavani
dc.contributor.authorMagaziner, Jay S
dc.contributor.authorMazor, Kathleen M
dc.contributor.authorMitchell, Susan L
dc.contributor.authorMody, Lona
dc.contributor.authorNace, David
dc.contributor.authorOuslander, Joseph
dc.contributor.authorReifsnyder, JoAnne
dc.contributor.authorResnick, Barbara
dc.contributor.authorZimmerman, Sheryl
dc.date.accessioned2022-01-19T16:20:16Z
dc.date.available2022-01-19T16:20:16Z
dc.date.issued2021-12-22
dc.identifier.urihttp://hdl.handle.net/10713/17603
dc.description.abstractAn effective clinical research effort in nursing homes to address prevention and treatment of COVID-19 faced overwhelming challenges. Under the Health Care Systems Research Network-Older Americans Independence Centers AGING Initiative, a multidisciplinary Stakeholder Advisory Panel was convened to develop recommendations to improve the capability of the clinical research enterprise in US nursing homes. The Panel considered the nursing home as a setting for clinical trials, reviewed the current state of clinical trials in nursing homes, and ultimately developed recommendations for the establishment of a nursing home clinical trials research network that would be centrally supported and administered. This report summarizes the Panel's recommendations, which were developed in alignment with the following core principles: build on available research infrastructure where appropriate; leverage existing productive partnerships of researchers with groups of nursing homes and nursing home corporations; encompass both efficacy and effectiveness clinical trials; be responsive to a broad range of stakeholders including nursing home residents and their care partners; be relevant to an expansive range of clinical and health care delivery research questions; be able to pivot as necessary to changing research priorities and circumstances; create a pathway for industry-sponsored research as appropriate; invest in strategies to increase diversity in study populations and the research workforce; and foster the development of the next generation of nursing home researchers. © 2021 AMDA – The Society for Post-Acute and Long-Term Care Medicineen_US
dc.description.urihttps://doi.org/10.1016/j.jamda.2021.11.034en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofJournal of the American Medical Directors Associationen_US
dc.rightsCopyright © 2021 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.en_US
dc.subjectCOVID-19en_US
dc.subjectNursing homesen_US
dc.subjectclinical trialsen_US
dc.subjectlong-term careen_US
dc.subjectpandemicen_US
dc.titleAdvancing Clinical Trials in Nursing Homes: A Proposed Roadmap to Success.en_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.jamda.2021.11.034
dc.identifier.pmid34953784
dc.source.journaltitleJournal of the American Medical Directors Association
dc.source.countryUnited States


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record